MetaVia Inc. Files 8-K with Financials
Ticker: MTVA · Form: 8-K · Filed: Apr 22, 2025 · CIK: 1638287
| Field | Detail |
|---|---|
| Company | Metavia INC. (MTVA) |
| Form Type | 8-K |
| Filed Date | Apr 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financials, reporting
TL;DR
MetaVia Inc. filed its 8-K, mostly financials. Nothing major to see here.
AI Summary
On April 22, 2025, MetaVia Inc. filed an 8-K report. The filing primarily consists of financial statements and exhibits, with no specific material events or disclosures detailed in the provided text beyond the standard reporting requirements. The company, formerly known as NeuroBo Pharmaceuticals, Inc. and Gemphire Therapeutics Inc., is incorporated in Delaware and based in Cambridge, MA.
Why It Matters
This filing indicates MetaVia Inc. is meeting its regular reporting obligations with the SEC, providing transparency to investors regarding its financial status and exhibits.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report primarily containing financial statements and exhibits, with no indication of significant new risks or material events.
Key Numbers
- 001-37809 — SEC File Number (Identifies the company's SEC filing history.)
- 47-2389984 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- MetaVia Inc. (company) — Registrant
- NeuroBo Pharmaceuticals, Inc. (company) — Former company name
- Gemphire Therapeutics Inc. (company) — Former company name
- 0001558370-25-005113 (accession_number) — Filing accession number
- 20250422 (date) — Filing date
- 0001638287 (cik) — Central Index Key
FAQ
What is the primary purpose of this 8-K filing by MetaVia Inc.?
The primary purpose of this 8-K filing by MetaVia Inc. is to report financial statements and exhibits as of April 22, 2025.
What were MetaVia Inc.'s previous names?
MetaVia Inc. was formerly known as NeuroBo Pharmaceuticals, Inc. and Gemphire Therapeutics Inc.
When did the name change from NeuroBo Pharmaceuticals, Inc. to MetaVia Inc. occur?
The name change from NeuroBo Pharmaceuticals, Inc. occurred on December 31, 2019.
Where is MetaVia Inc. headquartered?
MetaVia Inc. is headquartered at 545 Concord Avenue, Suite 210, Cambridge, Massachusetts, 02138.
What is MetaVia Inc.'s Standard Industrial Classification (SIC) code?
MetaVia Inc.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 22, 2025 regarding MetaVia Inc. (MTVA).